Akari Therapeutics, Plc (AKTX)
AKTX Stock Price Chart
Explore Akari Therapeutics, Plc interactive price chart. Choose custom timeframes to analyze AKTX price movements and trends.
AKTX Company Profile
Discover essential business fundamentals and corporate details for Akari Therapeutics, Plc (AKTX) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Biotechnology
IPO Date
6 Jan 2014
Employees
8.00
Website
https://www.akaritx.comCEO
Abizer Gaslightwala
Description
Akari Therapeutics, Plc is a clinical-stage biotechnology firm dedicated to advancing novel treatments for autoimmune and inflammatory disorders. The company's primary investigational therapy is nomacopan, an advanced, second-generation complement inhibitor. This drug is engineered to counteract both inflammatory and prothrombotic processes. Nomacopan holds promise for a range of serious conditions, including paroxysmal nocturnal hemoglobinuria (PNH), Guillain-Barré syndrome (GBS), hematopoietic stem cell transplant-associated thrombotic microangiopathy (HSCT-TMA), and bullous pemphigoid (BP). Akari's operations are headquartered in London, United Kingdom.
AKTX Financial Timeline
Browse a chronological timeline of Akari Therapeutics, Plc corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 18 Aug 2026
EPS estimate is -$1.39.
Earnings released on 19 May 2026
EPS came in at -$1.33 matching the estimated -$1.33.
Earnings released on 7 Apr 2026
EPS came in at -$2.99 falling short of the estimated -$1.80 by -66.11%.
Stock split effective on 31 Mar 2026
Shares were split 1 : 40 , changing the number of shares outstanding and the price per share accordingly.
Earnings released on 13 Nov 2025
EPS came in at -$0.10 falling short of the estimated -$0.04 by -150.00%.
Earnings released on 13 Aug 2025
EPS came in at -$0.06 surpassing the estimated -$0.09 by +33.33%.
Earnings released on 14 May 2025
EPS came in at -$0.14 .
Earnings released on 14 Apr 2025
EPS came in at -$0.17 surpassing the estimated -$1.00 by +83.00%.
Earnings released on 19 Nov 2024
EPS came in at -$9.60 falling short of the estimated -$0.60 by -1.50k%.
Earnings released on 19 Aug 2024
EPS came in at -$3.20 falling short of the estimated -$1.00 by -220.00%.
Earnings released on 15 May 2024
EPS came in at -$3.20 falling short of the estimated -$1.00 by -220.00%.
Earnings released on 29 Mar 2024
EPS came in at -$2.40 .
Earnings released on 3 Oct 2023
EPS came in at -$2.40 falling short of the estimated -$0.60 by -300.00%.
Earnings released on 26 Sept 2023
EPS came in at $2.00 surpassing the estimated -$1.00 by +300.00%.
Stock split effective on 17 Aug 2023
Shares were split 1 : 20 , changing the number of shares outstanding and the price per share accordingly.
Earnings released on 19 Jul 2023
EPS came in at -$0.10 falling short of the estimated -$0.07 by -42.86%.
Earnings released on 27 Mar 2023
EPS came in at -$4.00 .
Earnings released on 9 Mar 2023
EPS came in at -$0.00 .
Earnings released on 27 Sept 2022
EPS came in at -$2.00 .
Earnings released on 16 May 2022
EPS came in at -$96.00 .
Earnings released on 3 Dec 2021
EPS came in at -$0.60 .
Earnings released on 22 Sept 2021
EPS came in at -$2.20 .
AKTX Stock Performance
Access detailed AKTX performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.
